ArticleChemistry & biodiversity2026
Green Synthesised Silver Nanoparticle From Cotoneaster horizontalis, In Vitro and In Silico Antibacterial Properties.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fatty Acid Composition of Fixed Oil of Linum strictum and Its Antibiofilm, Anticoagulant, and α-Amylase Inhibitory Effects-In Vitro and In Silico Study.Chemistry & biodiversity · 2026Article
- Ultrasound-Assisted Extraction, Macroporous Resin Purification, and Antioxidant Activity of Chlorogenic Acid fromFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Antimicrobial resistance is becoming an epidemic and a leading cause of death worldwide. The search for drugs in nature has recently become more important, as natural molecules are more likely to be suitable for use as drugs. This study aimed to compare the antibacterial properties of the methanol extract of Cotoneaster horizontalis and its silver nanoparticles (AgNPs). The presence of metabolites was established using gas chromatography-tandem mass spectrometry (GC-MS/MS) and liquid chromatography (LC)-ESI-MS/MS. FT-IR, x-ray diffraction (XRD), FE-SEM and FE-SEM-EDAX were used to characterise the structure of the AgNPs. Identified molecules were docked in sortase-A (protein data bank [PDB] ID: 1T2P) of Staphylococcus aureus. Chlorogenic acid, isoquercitrin, hesperidin, quercetin-3-d-xyloside, rutin and vanillic acid were from the methanolic extract, whereas five fatty acids were identified from the hexane extract. The antibacterial activity was found to be dose dependent: 80 mg/mL for the extract and 10, 20, 40 and 80 mg/mL for Ag NPs on all studied bacterial strains. Amoxicillin (25 µg), tetracycline (30 µg) and gentamicin (10 µg) were used as standards. The docking scores demonstrated that major molecules inhibited sortase-A, and PASS analysis corroborated these results, suggesting membrane integrity antagonist as mechanism of antibacterial action. This study demonstrates that AgNPs synthesised from methanolic extract of C. horizontalis were more antibacterial than the methanol extract in vitro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.